HOME >> MEDICINE >> NEWS
ACE inhibitors may reduce death, heart attack and stroke in patients with coronary artery disease

Angiotension-converting enzyme (ACE) inhibitors, medications commonly used to treat hypertension (high blood pressure), may reduce cardiovascular risk and the risk of death in patients with coronary artery disease, according to a new analysis of previously conducted clinical trials reported in the April 10 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Several medications are available to treat patients with coronary artery disease, characterized by blockages in the vessels that supply blood to the heart, according to background information in the article. Researchers continue to examine the effectiveness of each medication in different patient groups. Previous research has shown that ACE inhibitors can help treat patients with coronary artery disease or congestive heart failure, which occurs when the heart loses its ability to pump blood efficiently, if that patient also has problems with the left ventricle, the lower left chamber of the heart. However, studies on the use of ACE inhibitors in patients with coronary artery disease but without heart failure or left ventricle dysfunction have had conflicting results.

Nicolas Danchin, M.D., F.E.S.C., Hpital Europen Georges Pompidou, Paris, and colleagues analyzed seven previous randomized and controlled trials of ACE inhibitors in patients with coronary artery disease. The studies tested five different ACE inhibitors and included a total of 33,960 patients, who were followed for a minimum of two years and an average of 4.4 years. In each trial, some patients were randomly selected to receive ACE inhibitors and others to receive placebos.

When the results of all the trials were analyzed together, treatment with ACE inhibitors significantly reduced the risk of death from any cause, cardiovascular death, myocardial infarction (heart attack) and stroke. The researchers also found that in studies that measured additional outcomes, ACE inhibitors appeared to reduce th
'"/>

Contact: Nicolas Danchin, M.D., F.E.S.C.
nicolas.danchin@egp.ap-hop-paris.fr
JAMA and Archives Journals
10-Apr-2006


Page: 1 2

Related medicine news :

1. COX inhibitors may weaken protective qualities of estrogen hormone therapy
2. ACE inhibitors help preserve kidney function in IgA nephropathy
3. Studies provide new evidence on risks associated with Cox-2 inhibitors and NSAIDs
4. Selective serotonin reuptake inhibitors antidepressants and risk of violent behavior
5. COX-2 inhibitors prescribed to reduce gastrointestinal toxicity prior to the market withdrawals
6. First trimester use of ACE inhibitors implicated in birth defects
7. Researchers resolve how COX inhibitors cause heart hazards, and offer alternative treatment strategy
8. COX-2 inhibitors significantly reduce risk of cancer
9. Regular use of selective COX-2 inhibitors decreases risk of breast cancer
10. Race/ethnicity predict lipids, heart-disease risk in HIV-1 patients on protease inhibitors
11. Blocking previously unrecognized links between inflammatory systems could make COX-2 inhibitors safe

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... August 31, 2020 , ... Cardiothoracic surgeons at Allegheny ... from Carnegie Mellon University (CMU) to develop a new heart monitoring device designed ... heart surgery. , The AGH/CMU team was recently awarded a “Trailblazer” grant from ...
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... cloud-based business management solution for chiropractors, announced today the launch of its integrated, ... professionals can start running their virtual practice in under 90 seconds. , ...
(Date:8/31/2020)... ... August 31, 2020 , ... In an effort to give back to ... 10 percent of each hotel room booked with a special new rate code to ... Indiana (RMHC-CNI) , effective immediately. Donations will be applied to any room type, ...
(Date:8/28/2020)... ... 28, 2020 , ... WHAT , Hespiro™ is a new ... conditions, including COVID-19, while reducing the need for scarce mechanical ventilators. It not ... and scrubs it free of carbon dioxide in a completely closed “rebreather” system, ...
(Date:8/28/2020)... ... August 28, 2020 , ... ... strongly suggest that obese individuals are at an increased risk of developing severe ... likely to catch COVID-19; however, because the same organ systems that the coronavirus ...
Breaking Medicine News(10 mins):
(Date:9/1/2020)... ... September 01, 2020 , ... Breast and ovarian cancers are common ... About 3% of breast cancers (about 7,500 women per year) and 10% of ovarian ... BRCA2 genes. Both genes are detectable in the Women’s Excellence Genetic Testing Program. ...
(Date:8/31/2020)... , ... August 31, 2020 , ... ... wellness-related technologies, today announced that they have invested $400,000 in PopBase, one of ... in collaboration with the Global Wellness Institute (GWI). , The competition was ...
(Date:8/31/2020)... PHOENIX (PRWEB) , ... August 31, 2020 , ... ... Mobile Sanitizing and Disinfecting - a broad-spectrum sanitization, disinfection and deodorization provider ... company will offer door-to-door sanitizing and disinfecting services for businesses and residents throughout ...
Breaking Medicine Technology:
Cached News: